AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Kaisita-M 100/500 Tablet ER

Prescription Icon
Prescription Required

Marketer

Strebi Pharmaceuticals Private Limited

Salt Composition

Sitagliptin (100mg) + Metformin (500mg)

Overview Kaisita-M 100/500 Tablet ER

Diabetics with type 2 mellitus may find relief from elevated blood glucose with Glycadia-Duo 100/500 ER tablets. This dual-action medication helps manage high blood sugar, potentially lessening the risk of diabetic complications like kidney disease and vision impairment, and may decrease the likelihood of cardiovascular events. Glycadia-Duo 100/500 ER might be prescribed alone or in conjunction with other antidiabetic therapies. Optimal results are achieved through its use alongside a balanced diet and regular physical activity. Dosage is personalized based on individual health status, glucose levels, and other medications. Consuming it with meals can minimize gastrointestinal discomfort. Consistent daily dosing at the same time each day is crucial for effectiveness; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regimen is vital for successful diabetes management, as lifestyle significantly impacts glucose control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential side effect, especially when combined with insulin or sulfonylureas; recognizing and managing hypoglycemic episodes is essential. This medication isn't universally suitable. Individuals with pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption should consult their physician before starting treatment. Similar caution is advised for pregnant or breastfeeding individuals. Inform your doctor about all other medications being taken to ensure safety and compatibility with Glycadia-Duo 100/500 ER, as interactions are possible. Alcohol consumption should be minimized due to its potential to lower blood sugar. Your doctor will monitor kidney function and blood glucose levels throughout the treatment period.

Uses of Kaisita-M 100/500 Tablet ER

Managing type 2 diabetes

Major Benefits of Kaisita-M 100/500 Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Kaisita-M 100/500 Tablet ER with a meal.

Common Side effects of Kaisita-M 100/500 Tablet ER:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Kaisita-M 100/500 Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Kaisita-M 100/500 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

How Kaisita-M 100/500 Tablet ER works:

Kaisita-M 100/500 Extended-Release tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Kaisita-M 100/500 Tablet ER is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Kaisita-M 100/500 Extended-Release tablets during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to any prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Kaisita-M 100/500mg tablet likely poses a risk during lactation. Available human data indicate potential transfer to breast milk, possibly causing infant harm.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Kaisita-M 100/500 ER tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Kaisita-M 100/500 ER tablets are contraindicated in individuals with severe kidney disease. Close monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

The extended-release Kaisita-M 100/500 tablet is contraindicated for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Kaisita-M 100/500 Tablet ER :

Should you forget a dose of Kaisita-M 100/500 Tablet ER, take it immediately if you remember. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your normal dosing regimen. Avoid taking a double dose.

Facts to Know About Kaisita-M 100/500 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Kaisita-M 100/500 Tablet ER

Kaisita-M 100/500 Tablet ER combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Kaisita-M 100/500 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and urinary issues), and cognitive changes (including balance problems). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Kaisita-M 100/500 Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients allergic to Kaisita-M 100/500 Tablet ER components or excipients should not use it. Its use is contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Kaisita-M 100/500 Tablet ER with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Kaisita-M 100/500 Tablet ER can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding its use in patients with kidney disease, the elderly, or those who consume large quantities of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these symptoms occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Kaisita-M 100/500 Tablet ER combines sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Kaisita-M 100/500 Tablet ER may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Kaisita-M 100/500 Tablet ER components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Kaisita-M 100/500 Tablet ER with alcohol is unsafe and may heighten the risk of lactic acidosis.
Kaisita-M 100/500 Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). While rare, this side effect necessitates avoiding the drug in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Kaisita-M 100/500 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifested as numbness, tingling in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Kaisita-M 100/500 Tablet ER combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Kaisita-M 100/500 Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Kaisita-M 100/500 Tablet ER is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Kaisita-M 100/500 Tablet ER with alcohol is unsafe and may heighten the risk of lactic acidosis.
Kaisita-M 100/500 Tablet ER can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA, Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Kaisita-M 100/500 Tablet ER can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; ensure it remains inaccessible to children, pets, and others.
Kaisita-M 100/500 Tablet ...
183